Hyperhomocysteinemia as a new risk factor for different diseases;Hiperhomocysteinemia jako nowy czynnik ryzyka wielu chorób

Advances in Clinical and Experimental Medicine

Volumn 15, Issue 5, 2006, Pages 897-903

  Łubińska, Monika ^a   Kazimierska, Ewa ^a   Sworczak, Krzysztof ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Arteriosclerosis; Coabulation disorders; Depression; Homocysteine; Hyperhomocysteinemia

Indexed keywords

HOMOCYSTEINE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; DEEP VEIN THROMBOSIS; HUMAN; HYPERHOMOCYSTEINEMIA; MENTAL DISEASE; PATHOGENESIS; PREGNANCY DISORDER; REVIEW; RISK ASSESSMENT;

EID: 36148931235     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M, DACH - LIGA Homocystein e.V: DACH - LIGA homocystein (German, Austrian, and Swiss homocysteine society) consensus paper on the rational clinical use of homocysteine, folic acid, and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 2003, 41, 1392-1403.
2. Clark R, Collins R, Lewington S, Donald A: Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002, 288, 2015-2022.
3. Refsum H, Smith AD, Ueland PM, Nexo E, Clark R, McPartlin J, Johnson C, Engbaek F, Schneede J, McPartlin C, Scott IM: Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion. Clin Chem 2004, 50, 3-32.
4. Bostom AG, Culleton BF: Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol 1999, 10, 891-900.
5. Walker MC, Smith GN, Perkins SL, Kelly EJ, Garner PR: Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 1999, 180, 660-664.
6. de Bree A, Verschuren WM, Blom HJ, Kromhout D: Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol 2001, 154, 150-154.
7. Refsum H, Yjanik CS, Gadkari M, Schneede J, Vollset SE, Orning L, Guttormsen AB, Joglekar A, Sayyad MG, Ulwik A, Ueland PM: Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 2001, 74, 233-241.
8. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IM: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993, 270, 2693-2698.
9. Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ, Delport R, Potgieter HC: Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994, 124, 1927-1933.
10. 12, i kwasu foliowego w surowicy u chorych z alkoholowa choroba watroby. Pol Merk Lek 2003, 15, 140-143.
11. Moustapha A, Gupta A, Robinson K, Arheart K, Jacobson DW, Schreiber MJ, Dennis VW: Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis. Kidney Int 1999, 55, 1470-1475.
12. Kutluana U, Simsek I, Akarsu M, Kupelioglu A, Karasu S, Altekin E: Is there a possible relation between atrophic gastritis and premature atherosclerosis? Helicobacter 2005, 10, 623-629.
13. Lewandowski K: Hyperhomocysteinemia jako czynnik ryzyka rozwoju zmian naczyniowych. Acta Haematol Pol 1998, 29, 157-169.
14. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Huevel LP, Mariman EC, den Heyer M, Rozen R, Bloom HJ: Mutated methylenetetrahydrofolate reductase as risk factor for spina bifida. Lancet 1995, 346, 1070-1071.
15. Lucock M: Is folic acid the ultimate functional food component for disease prevention? BMJ 2004, 328, 211-214.
16. Korzets A, Ori Y, Chagnac A, Weinstein T, Herman M, Zevin D, Malachi T, Gafter U: Erythropoetin, folic acid deficiency and hyperhomocysteinemia: is there a possible relationship in chronically hemodialyzed patients? Clin Nephrol 2000, 53, 48-54.
17. Lilien M, Duran M, Van Hoeck K, Poll-The BT, Schroder C: Hyperhomocysteinemia in children with chronic renal failure. Nephrol Dial Transplant 1999, 14, 366-368.
18. 12, and sulfur amino acid levels in patients with renal failure. Pediatr Nephrol 2001, 16, 127-132.
19. Orzechowska-Pawilojć A, Lewczuk A, Sworczak K: Wplyw hormonów tarczycy na poziom homocysteiny w aspekcie ryzyka rozwoju zmian miażdżycowych. Endokrynol Pol 2005, 56, 194-202.
20. Catargi B, Parrot-Roulaud F, Cochet C, Ducassou D, Roger P, Tabarin A: Homocysteine, hypothyroidism, and effect of thyroid hormone replacement. Thyroid 1999, 9, 1163-1166.
21. Szymczak E., Gajewska J., Laskowska-Klita T.- Wybrane niezależne czynniki ryzyka miażdżycy u dzieci jako podstawa wczesnego wykrywania zagrożenia choroba niedokrwienna serca. Pol Merkuriusz Lek 2001, 61, 56-59.
22. Nappo F, De Rosa N, Marfella R, De Lucia D, Ingrosso D, Perna AF, Farzati B, Giugliano D: Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 1999, 281, 2113-2118.
23. Haijar KA, Mauri L, Jacovina AT, Zhong F, Mirza UA, Padovan JC, Chait BT: Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. J Biol Chem 1998, 273, 9987-9993.
24. Lentz SR: Mechanism of homocysteine-induced atherothrombosis. J Thromb Haemost 2005, 3, 1646-1654.
25. Wald DS, Law M, Morris JK: Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002, 325, 1202-1206.
26. Stampfer MJ, Willett WC: Homocysteine and marginal vitamin deficiency. The importance of adequate vitamin intake. JAMA 1993, 270, 2726-2727.
27. 6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet 2000, 355, 517-522.
28. Moustapha A, Naso, A, Nahlawi M, Gupta A, Arheart KL, Jacobsen DW, Robinson K, Dennis VW: Prospective study of hyperhomocysteinemia as a adverse cardiovascular risk factor in end-stage renal diseaese. Circulation 1998, 97, 138-141.
29. den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR: Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996, 334, 752-762.
30. Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH: Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000, 69, 228-232.
31. 12 and homocysteine in major depressive disorder. Am J Psychiatry 1997, 154, 426-428.
32. 12 status in confirmed Alzheimer's disease as revealed by serum holotranscobalamin. J Neurol Neurosurg Psychiatry 2003, 74, 959-961.
33. Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith D: Plasma homocysteine levels, cerebrovascular risk factor, and cerebral white matter changes in patients with Alzheimer disease. Arch Neurol 2002, 59, 787-793.
34. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB Wilson PW, Wolf PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Eng J Med 2002, 346, 476-483.
35. Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Jolles J, Clark R, Breteler MM: Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002, 59, 1375-1380.
36. Levine J, Stahl Z, Sela BA, Gavendo S, Ruderman V, Belmaker RH: Elevated homocysteine levels in young male patients with schizophrenia. Am J Psychiatry 2002, 159, 1790-1792.
37. Hogg BB, Tamura T, Johnston KE, Dubard MB, Goldenberg RL: Second trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction. Am J Obstet Gynecol 2000, 183, 805-809.
38. Cotter AM, Molloy AM, Scott JM, Daly SF: Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol 2001, 185, 781-785.
39. Ronnerberg AG, Goldman MB, Chen D, Aitken IW, Willett WC, Selhub J, Xu X: Preconception folate and vitamin B (6) status and clinical spontaneous abortion in Chinese women. Obstet Gynecol 2002, 100, 107-113.
40. Wong WY, Eskes TK, Kuijpers-Jagtman AM, Spauwen PH, Steegers EA, Thomas CM, Hamel BC, Blom HJ, Steegers-Theunissen RP: Nonsyndromic orofacial clefts: association with maternal hyperhomocysteinemia. Teratology 1999, 60, 253-257.
41. van der Put NM, van Straaten HW, Trijbels FJ, Blom HJ: Folate, homocysteine and neural tube defects: an overview. Exp Biol Med 2001, 226, 243-270.
42. Rosenblatt DS, Whitehead VM: Cobalamin and folate deficiency: acquired and hereditary disorders in children. Semin Hematol 1999, 36, 19-34.
43. Monsen BA, Ueland PM: Homocysteine and methylinalonic acid in diagnosis and risk assessment from infancy to adolescence. Am J Clin Nutr 2003, 78, 7-21.